Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children

NCT02720705 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-07-14

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy of transbucal dexmedetomidine given in preschool children undergoing tonsillectomy operations in the prevention sevoflurane agitation.

Conditions

  • Agitation

Interventions

DRUG

Dexmedetomidine

oral dexmedetomidine

DRUG

saline

2ml 0.9% saline administered orally half an hour before induction of anesthesia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Halla s Abdel-Ghaffar Abdel-Ghaffar, MD · assisstant professor in anesthesia and intensive care departement,faculty of medicine,Assiut university,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2018-10-31
Completion
2018-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720705 on ClinicalTrials.gov